Generic name: Bencyclane hydrogen fumarate

Classification

Peripheral Vasodilators & Cerebral Activators / Haemorrheologicals

Indications

Cerebral & peripheral vascular disorders, sequelae of apoplexy (not in acute phase). Vascular eye disorders, diabetic retinopathy, sudden deafness due to vascular disorders, diabetic angiopathies, functional vascular disorders.

Dosage

1 tab tid. May be increased to 2 tab tid.

Contraindications

Severe hepatic, renal & decompensated cardiac insufficiency, recent MI, AV block, recent apoplexy (until the 3rd day), severe circulatory collapse; simultaneous therapy w/ beta-blockers.

Precautions

Patients susceptible to cerebral seizures; residual urine formation due to prostatic hypertrophy.

Interactions

May potentiate action of antihypertensives, nitrates, a-blockers, tricyclic psychotropic drugs.